---
schema_version: "secwatch.filing_event.v1"
accession: "0000874716-25-000011"
form_type: "8-K"
ticker: "IDXX"
cik: "0000874716"
company_name: "IDEXX LABORATORIES INC /DE"
filed_at: "2025-02-14T23:59:59+00:00"
generated_at: "2026-05-26T21:49:04.285528+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# IDEXX director Asha Collins resigns from Board, effective immediately

## Summary
- Dr. Asha Collins resigned from the Board of Directors on February 13, 2025.
- Resignation was not due to any disagreement with the Company on operations, policies, or practices.
- Board size reduced from ten to nine directors following the resignation.
- Company and Board thanked Dr. Collins for her service.

## SEC filing metadata
- accession: 0000874716-25-000011
- form_type: 8-K
- ticker: IDXX
- cik: 0000874716
- company_name: IDEXX LABORATORIES INC /DE
- filed_at: 2025-02-14T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/874716/000087471625000011/0000874716-25-000011-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/874716/000087471625000011/idxx-20250213.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000874716-25-000011
- JSON: https://secwatch.observer/filing/0000874716-25-000011.json
- Plain text: https://secwatch.observer/filing/0000874716-25-000011.txt

## Key facts
- Executive change
  Dr. Asha Collins resigned as Director at IDEXX LABORATORIES INC /DE.
  - Action: resigned
  - Role: Director
  source text: On February 13, 2025, Dr. Asha Collins resigned from the Board of Directors (the “Board”) of IDEXX Laboratories, Inc. (the “Company”), effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/874716/000087471625000011/0000874716-25-000011-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.